{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:59:03Z","timestamp":1761901143607,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.msard.2016.06.014","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T02:01:03Z","timestamp":1467079263000},"page":"54-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report"],"prefix":"10.1016","volume":"9","author":[{"given":"Jahir Andres","family":"Miranda Acu\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.msard.2016.06.014_bib1","first-page":"183","article-title":"Influenza vaccine and autoimmunity","volume":"11","author":"Agmon-Levin","year":"2009","journal-title":"Isr. Med. Assoc. J."},{"issue":"9648","key":"10.1016\/j.msard.2016.06.014_bib2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2016.06.014_bib3","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1212\/NXI.0000000000000029","article-title":"IV immunoglobulin confounds JC virus antibody serostatus determination","volume":"1","author":"Kister","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"23","key":"10.1016\/j.msard.2016.06.014_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMc1214233","article-title":"JC viremia in natalizumab-treated patients with multiple sclerosis","volume":"368","author":"Major","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2016.06.014_bib5","first-page":"1","article-title":"Stratification and monitoring of natalizumab associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group","volume":"0","author":"McGuigan","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2016.06.014_bib6","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti\u2013JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2016.06.014_bib7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1177\/1352458515599681","article-title":"Anti-JC virus antibody titres increase over time with natalizumab treatment","volume":"21","author":"Raffel","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.06.014_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/03009740500474552","article-title":"Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus","volume":"35","author":"Tarj\u00e1n","year":"2006","journal-title":"Scand. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.msard.2016.06.014_bib9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1177\/1352458514567728","article-title":"Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"Vennegoor","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2016.06.014_bib10","first-page":"S343","article-title":"An update on new and emerging therapies for relapsing-remitting multiple sclerosis","volume":"19","author":"Weinstock-Guttman","year":"2013","journal-title":"Am. J. Manag. Care"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034816300980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:39:13Z","timestamp":1761899953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034816300980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":10,"alternative-id":["S2211034816300980"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2016.06.014","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2016.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}